Nicotinell Mondspray Mint

Nicotine, the active ingredient in Nicotinell Mondspray Mint, is a nicotinic agonist presented as a oral spray for oromucosal use. It treats nicotine dependence and helps adult smokers who wish to quit. GNH USA supplies Nicotinell Mondspray Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine is used in smoking cessation to reduce withdrawal symptoms by acting on nicotinic receptors.

Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms. Tobacco dependence: supports gradual reduction of cigarette consumption. Relapse prevention: assists former smokers in maintaining abstinence.

Common Side Effects: - Mouth irritation or tingling - Throat discomfort - Nausea or mild stomach upset - Headache or dizziness

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or difficulty breathing - Significant increase in blood pressure or arrhythmia - Severe nausea or vomiting requiring medical attention

Use Nicotinell Mondspray Mint only under the guidance of a qualified healthcare professional.

Medical supervision required: follow prescriber instructions for duration and frequency. Not for non‑smokers: avoid use if you do not currently use tobacco products. Allergy caution: discontinue if signs of hypersensitivity appear. Cardiovascular caution: consult a doctor if you have hypertension or heart disease. Pregnancy and breastfeeding: discuss risks with a healthcare provider before use. Store at room temperature: keep in the original container, protect from moisture and direct heat.

Nicotine may interact with several medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Certain antihypertensive agents: additive blood‑pressure lowering effects. - Insulin or oral hypoglycemics: possible alteration of glucose control.

Moderate Interactions (Monitor Closely): - Caffeine‑containing products: may increase stimulation. - Select antidepressants (e.g., SSRIs): potential for heightened side effects.